QINLOCK (ripretinib) for the Treatment of Gastrointestinal Stromal Tumour

QINLOCK™ (ripretinib) is indicated for the treatment of advanced gastrointestinal stromal tumor (GIST). Credit: Deciphera Pharmaceuticals, Inc.



  • QINLOCK (ripretinib)
  • QINLOCK (ripretinib)
  • QINLOCK (ripretinib)